Does amide proton transfer-weighted MRI have diagnostic and differential value in ovarian cystic and predominantly cystic lesion?

other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-10

Amide proton transfer-weighted MRI accurately differentiated ovarian lesions by showing significant differences in MTRasym values between normal and diseased tissues, and various benign and malignant cystic components.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text

This study evaluated whether amide proton transfer-weighted (APTw) MRI can distinguish cystic or predominantly cystic ovarian lesions by comparing amide proton transfer–related magnetization transfer asymmetry (MTRasym) values across multiple lesion types. Forty-nine patients underwent 3T APTw MRI before surgery (with 20 volunteers as controls), and lesions were grouped into normal ovarian tissue, solid components of malignant lesions, cystic/functional cyst fluid, benign cysts (e.g., cystadenomas), and endometriomas, using statistical group comparisons and ROC analyses. The study found significant MTRasym value differences between many cystic and solid tissue groups, with ROC AUCs ranging from 0.813 to 1.0, and concludes that APTw imaging has diagnostic value for differentiating functional cysts, endometriomas, and cystadenomas from malignant tumors, while noting no dataset was generated or analyzed beyond the reported imaging comparisons. This paper is centrally about endometriosis — specifically, it reports diagnostic discrimination of ovarian endometriomas from other cystic ovarian lesions using APTw-MRI MTRasym values.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

OBJECTIVES: This study aims to evaluate the diagnostic value of amide proton transfer-weighted (APTw) imaging in distinguishing cystic or predominantly cystic ovarian lesions. MATERIALS AND METHODS: 49 patients underwent APTw imaging at 3T-MR before surgery, with 20 volunteers serving as the control group. Participants were divided into the following groups: solid components of normal ovaries (Group A, n = 29), solid components of malignant lesions (Group B, n = 7), cystic fluid of follicles (Group C, n = 31), cystic fluid of benign lesions (Group D, n = 46), functional cysts (Group d1, n = 8), endometriomas (Group d2, n = 28), cystadenomas (Group d3, n = 10), and cystic fluid of malignant lesions (Group E, n = 12). Independent t-tests or Mann-Whitney U tests and one-way ANOVA were used to compare group differences. Receiver operating characteristic (ROC) analysis was used to evaluate the diagnostic efficacy in distinguishing between different lesions. RESULTS: For solid components, significant differences in MTRasym values were observed between Groups A and B (P < 0.001). For cystic components, significant differences were found between Groups C and D, C and E, d1 and d2, d2 and d3, d1 and d3, C and d2, C and d3, E and d1, and E and d2 (all P < 0.01). ROC analysis of these results showed high AUC values (ranging from 0.813 to 1.0), all P < 0.05. CONCLUSIONS: APTw can reveal differences in MTRasym values between normal and diseased ovarian tissues, demonstrating high clinical value in differentiating functional cysts, endometriomas, and cystadenomas, as well as distinguishing benign lesions (functional cysts or endometriomas) from malignant tumors.
Full text 10,695 characters · extracted from oa-doi-fallback · 5 sections · click to expand

Abstract

Objectives This study aims to evaluate the diagnostic value of amide proton transfer-weighted (APTw) imaging in distinguishing cystic or predominantly cystic ovarian lesions.

Materials and methods

49 patients underwent APTw imaging at 3T-MR before surgery, with 20 volunteers serving as the control group. Participants were divided into the following groups: solid components of normal ovaries (Group A, n = 29), solid components of malignant lesions (Group B, n = 7), cystic fluid of follicles (Group C, n = 31), cystic fluid of benign lesions (Group D, n = 46), functional cysts (Group d1, n = 8), endometriomas (Group d2, n = 28), cystadenomas (Group d3, n = 10), and cystic fluid of malignant lesions (Group E, n = 12). Independent t-tests or Mann-Whitney U tests and one-way ANOVA were used to compare group differences. Receiver operating characteristic (ROC) analysis was used to evaluate the diagnostic efficacy in distinguishing between different lesions.

Results

For solid components, significant differences in MTRasym values were observed between Groups A and B (P < 0.001). For cystic components, significant differences were found between Groups C and D, C and E, d1 and d2, d2 and d3, d1 and d3, C and d2, C and d3, E and d1, and E and d2 (all P < 0.01). ROC analysis of these results showed high AUC values (ranging from 0.813 to 1.0), all P < 0.05.

Conclusions

APTw can reveal differences in MTRasym values between normal and diseased ovarian tissues, demonstrating high clinical value in differentiating functional cysts, endometriomas, and cystadenomas, as well as distinguishing benign lesions (functional cysts or endometriomas) from malignant tumors. Similar content being viewed by others Data availability No datasets were generated or analysed during the current study.

References

Reinhold C, Rockall A, Sadowski E A, et al. Ovarian-Adnexal Reporting Lexicon for MRI: A White Paper of the ACR Ovarian-Adnexal Reporting and Data Systems MRI Committee. J Am Coll Radiol, 2021; 18: 713–729 Wang Q, Yu D, Wang F. Clinical and Computed Tomographic Features of Ovarian Lesions in Infants, Children, and Adolescents: A Series of 222 Cases. J Pediatr Adolesc Gynecol, 2021; 34: 387–393 Farghaly S A. Current diagnosis and management of ovarian cysts. Clin Exp Obstet Gynecol, 2014; 41: 609–12 Ackerman S, Irshad A, Lewis M, et al. Ovarian cystic lesions: a current approach to diagnosis and management. Radiol Clin North Am, 2013; 51: 1067–85 Baseviciene I, Martinkiene I, Basevicius A, et al. Functional ovarian cysts in girls. Medicina (Kaunas), 2003; 39: 902–9 Doret M, Raudrant D. Functional ovarian cysts and the need to remove them. Eur J Obstet Gynecol Reprod Biol, 2001; 100: 1–4 Ng S W, Norwitz S G, Taylor H S, et al. Endometriosis: The Role of Iron Overload and Ferroptosis. Reprod Sci, 2020; 27: 1383–1390 Park S B, Lee J B. MRI features of ovarian cystic lesions. J Magn Reson Imaging, 2014; 40: 503–15. Penny SM. Ovarian Cancer: An Overview. Radiol Technol. 2020; 91:561–575 Imaoka I, Wada A, Kaji Y, et al. Developing an MR imaging strategy for diagnosis of ovarian masses. Radiographics, 2006; 26: 1431–48 Zhang H, Mao Y, Chen X, et al. Magnetic resonance imaging radiomics in categorizing ovarian masses and predicting clinical outcome: a preliminary study. Eur Radiol, 2019; 29: 3358–3371 Nakai A, Koyama T, Fujimoto K, et al. Functional MR imaging of the uterus. Magn Reson Imaging Clin N Am, 2008; 16: 673– 84, ix Koyama T, Togashi K. Functional MR imaging of the female pelvis. J Magn Reson Imaging, 2007; 25: 1101–12 Vandecaveye V, Dresen R, De Keyzer F. Novel imaging techniques in gynaecological cancer. Curr Opin Oncol, 2017; 29: 335–342 Wei M, Bo F, Cao H, et al. Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging for malignant ovarian tumors: a systematic review and meta-analysis. Acta Radiol, 2021; 62: 966–978 Sadowski E A, Bennett L K, Chan M R, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology; 2007, 243: 148–57 Levy A, Medjhoul A, Caramella C, et al. Interest of diffusion-weighted echo-planar MR imaging and apparent diffusion coefficient mapping in gynecological malignancies: a review. J Magn Reson Imaging, 2011; 33: 1020–7 Kim H J, Lee S Y, Shin Y R, et al. The Value of Diffusion-Weighted Imaging in the Differential Diagnosis of Ovarian Lesions: A Meta-Analysis. PLoS One, 2016; 11: e0149465 Thomassin-Naggara I, Daraï E, Cuenod C A, et al. Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses. Eur Radiol, 2009; 19: 1544–52 Pankowska A, Kochalska K, Łazorczyk A, et al. Chemical exchange saturation transfer (CEST) as a new method of signal obtainment in magnetic resonance molecular imaging in clinical and research practice. Pol J Radiol, 2019; 84: e147-e152 Dou W, Lin C E, Ding H, et al. Chemical exchange saturation transfer magnetic resonance imaging and its main and potential applications in pre-clinical and clinical studies. Quant Imaging Med Surg, 2019; 9: 1747–1766 Zhou J, Zaiss M, Knutsson L, et al. Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors. Magn Reson Med, 2022; 88: 546–574 Jones K M, Pollard A C, Pagel M D. Clinical applications of chemical exchange saturation transfer (CEST) MRI. J Magn Reson Imaging, 2018; 47: 11–27 Ishimatsu K, Nishie A, Takayama Y, et al. Amide proton transfer imaging for differentiating benign ovarian cystic lesions: Potential of first time right. Eur J Radiol, 2019; 120: 108656 Li Y, Lu X, Chen L, et al. Identification of ovarian endometriotic cysts in cystic lesions of the ovary by amide proton transfer weighted imaging and R2 * mapping. Clin Radiol 2023; 78: e106-e12 Yu Y, Song X, Zeng Z, et al. Amide proton transfer weighted MRI in differential diagnosis of ovarian masses with cystic components: A preliminary study. Magn Reson Imaging. 2023; 103:216–223 Meng N, Wang X, Sun J, et al. Evaluation of amide proton transfer-weighted imaging for endometrial carcinoma histological features: a comparative study with diffusion kurtosis imaging. Eur Radiol, 2021; 31: 8388–8398 Meng N, Fang T, Feng P, et al. Amide Proton Transfer-Weighted Imaging and Multiple Models Diffusion-Weighted Imaging Facilitates Preoperative Risk Stratification of Early-Stage Endometrial Carcinoma. J Magn Reson Imaging, 2021; 54: 1200–1211 Zhou J, Lal B, Wilson D A, et al. Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med, 2003; 50: 1120–6 Salhotra A, Lal B, Laterra J, et al. Amide proton transfer imaging of 9L gliosarcoma and human glioblastoma xenografts. NMR Biomed, 2008; 21: 489–97 Grossman R, Tyler B, Brem H, et al. Growth properties of SF188/V + human glioma in rats in vivo observed by magnetic resonance imaging. J Neurooncol, 2012; 110: 315–23 Zhou J, Heo H Y, Knutsson L, et al. APT-weighted MRI: Techniques, current neuro applications, and challenging issues. J Magn Reson Imaging, 2019; 50: 347–364 Friedrich M, Friedrich D, Kraft C, et al. Multimodal Treatment of Primary Advanced Ovarian Cancer. Anticancer Res, 2021; 41: 3253–3260 Ohya A, Fujinaga Y. Magnetic resonance imaging findings of cystic ovarian tumors: major differential diagnoses in five types frequently encountered in daily clinical practice. Jpn J Radiol, 2022; 40: 1213–1234 Sun P Z, Zhou J, Sun W, et al. Detection of the ischemic penumbra using pH-weighted MRI. J Cereb Blood Flow Metab, 2007; 27: 1129–36 Zheng Y, Wang X, Zhao X. Magnetization Transfer and Amide Proton Transfer MRI of Neonatal Brain Development. Biomed Res Int, 2016; 2016: 3052723 Li W N, Hsiao K Y, Wang C A, et al. Extracellular vesicle-associated VEGF-C promotes lymphangiogenesis and immune cells infiltration in endometriosis. Proc Natl Acad Sci U S A, 2020; 117: 25859–25868 Symons L K, Miller J E, Tyryshkin K, et al. Neutrophil recruitment and function in endometriosis patients and a syngeneic murine model. Faseb j, 2020; 34: 1558–1575 Cottrell G S. Roles of proteolysis in regulation of GPCR function. Br J Pharmacol, 2013; 168: 576–90 Hallberg I, Plassmann M, Olovsson M, et al. Suspect and non-target screening of ovarian follicular fluid and serum - identification of anthropogenic chemicals and investigation of their association to fertility. Environ Sci Process Impacts, 2021; 23: 1578–1588 Velazquez A, Reyes A, Chargoy J, et al. Amino acid and protein concentrations of human follicular fluid. Fertil Steril, 1977; 28: 96–100 Tanaka Y, Nakai G, Yamamura K, et al. Analysis of MRI Values and Hemoglobin and Total Protein Concentrations of Cystic Ovarian Tumors. J Magn Reson Imaging, 2019; 49: 1133–1140 Marko J, Marko K I, Pachigolla S L, et al. Mucinous Neoplasms of the Ovary: Radiologic-Pathologic Correlation. Radiographics, 2019; 39: 982–997 Klemi P J. Pathology of mucinous ovarian cystadenomas. I. Argyrophil and argentaffin cells and epithelial mucosubstances. Acta Pathol Microbiol Scand A, 1978; 86a: 465–70 Author information Authors and Affiliations Contributions DD and LC contribute equally to this article and should be considered co-first authors. DD: Data curation, Formal analysis, Investigation, Writing - review & editing. LC: Conceptualization, Formal analysis, Software, Writing - original draft. CM: Conceptualization, Methodology, Resources. BY: Data curation, Formal analysis, Investigation. DP: Software, Supervision, Writing - review & editing. TZ: Software, Methodology, Resources. DY: Conceptualization, Methodology, Resources, Supervision. FW: Conceptualization, Methodology, Supervision, Writing - review & editing.All authors reviewed the manuscript. Corresponding author Ethics declarations Competing interests The authors declare no competing interests. Additional information Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Rights and permissions Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. About this article Cite this article Ding, D., Chang, L., Men, C. et al. Does amide proton transfer-weighted MRI have diagnostic and differential value in ovarian cystic and predominantly cystic lesion?. Abdom Radiol 50, 3262–3271 (2025). https://doi.org/10.1007/s00261-024-04768-w Received: Revised: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s00261-024-04768-w

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Magnetic Resonance Imaging Magnetic Resonance Imaging Magnetic Resonance Imaging Magnetic Resonance Imaging Magnetic Resonance Imaging Magnetic Resonance Imaging Magnetic Resonance Imaging Magnetic Resonance Imaging Magnetic Resonance Imaging Magnetic Resonance Imaging Magnetic Resonance Imaging Magnetic Resonance Imaging Ovarian Cysts Ovarian Cysts Ovarian Cysts Ovarian Cysts Ovarian Cysts Ovarian Cysts Ovarian Cysts Ovarian Cysts

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
pubmed
last seen: 2026-06-02T00:32:13.601867+00:00
unpaywall
last seen: 2026-05-11T08:34:28.763810+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine